Ticker Wise breaks down US stocks in plain English — the business, the numbers, and the risks most people skip.
Each video takes one company apart: what it actually does, how it makes money, and what the valuation is really telling you. Expect bear, base and bull case price targets, sanity checks on stocks trading at wild premiums, and honest deep dives into biotech approvals, AI infrastructure and small-cap movers.
Recent breakdowns: Moderna at a 31x premium, HPE's $92B Juniper acquisition, Replimune's IGNYTE-3 risk, SELLAS Life Sciences and Eton Pharmaceuticals.
If you want the homework done before you put money in, subscribe.
Ticker Wise — stock research, plain English.
Nothing on this channel is financial advice. All opinions and analysis are for educational purposes only.